Lilly Plans $53 Million Expansion in Japan
INDIANAPOLIS (AP) _ Eli Lilly and Co. plans to build a $53 million facility in Japan to produce injectable pharmaceutical products, officials said Wednesday.
The automated facility is expected to be built by early 1995 in an industrial park in Kobe, about 300 miles southwest of Tokyo. It will employ about 50 people, the company said.
The plant ″signifies our increasing ability to successfully compete in the Japanese pharmaceutical market, the second largest in the world,″ said Jean- Pierre Millon, president and general manager of Eli Lilly Japan.
Lilly’s human growth hormone product, Humatrope, will be the first product made in the new facility, the statement said. The plant also may be used to manufacture antibiotics and cancer treatment agents.
Lilly has marketed products in Japan since the early 1900s. It established its own operations there in 1986. Lilly employs about 500 people in Japan.